Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer.


Journal

Clinical cancer research : an official journal of the American Association for Cancer Research
ISSN: 1557-3265
Titre abrégé: Clin Cancer Res
Pays: United States
ID NLM: 9502500

Informations de publication

Date de publication:
01 04 2019
Historique:
received: 17 07 2018
revised: 10 09 2018
accepted: 12 11 2018
pubmed: 18 11 2018
medline: 12 5 2020
entrez: 17 11 2018
Statut: ppublish

Résumé

The introduction of HER2-targeted therapy for breast and gastric patients with

Identifiants

pubmed: 30442682
pii: 1078-0432.CCR-18-2275
doi: 10.1158/1078-0432.CCR-18-2275
pmc: PMC6445731
mid: NIHMS1512385
doi:

Substances chimiques

Antineoplastic Agents 0
Antineoplastic Agents, Immunological 0
Biomarkers, Tumor 0
ERBB2 protein, human EC 2.7.10.1
Receptor, ErbB-2 EC 2.7.10.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2033-2041

Subventions

Organisme : NCI NIH HHS
ID : K12 CA088084
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States

Informations de copyright

©2018 American Association for Cancer Research.

Références

Cancer Discov. 2017 Aug;7(8):818-831
pubmed: 28572459
Oncogene. 2007 Oct 4;26(45):6469-87
pubmed: 17471238
Lancet Oncol. 2016 Jun;17(6):738-746
pubmed: 27108243
Nat Med. 2018 May;24(5):638-646
pubmed: 29686424
Clin Cancer Res. 2017 Oct 1;23(19):5687-5695
pubmed: 28679771
Cancer Cell. 2006 Jul;10(1):25-38
pubmed: 16843263
Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8933-8
pubmed: 12853564
Nature. 2004 Sep 30;431(7008):525-6
pubmed: 15457249
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
PLoS One. 2011;6(10):e26760
pubmed: 22046346
Clin Cancer Res. 2012 Sep 15;18(18):4910-8
pubmed: 22761469
Lancet Oncol. 2018 Jul;19(7):880-888
pubmed: 29804905
JAMA Oncol. 2018 Sep 1;4(9):1214-1220
pubmed: 29955792
JAMA Oncol. 2017 Aug 1;3(8):1094-1101
pubmed: 28426845
J Clin Oncol. 2013 Jun 1;31(16):1997-2003
pubmed: 23610105
Cancer Discov. 2017 Jun;7(6):575-585
pubmed: 28274957
Breast Cancer Res Treat. 2017 Nov;166(2):339-349
pubmed: 28762010
Cell. 1987 Dec 24;51(6):1063-70
pubmed: 3500791
Cancer Discov. 2011 Nov;1(6):508-23
pubmed: 22586653
Science. 1987 Jan 9;235(4785):177-82
pubmed: 3798106
Nat Rev Mol Cell Biol. 2001 Feb;2(2):127-37
pubmed: 11252954
J Mol Diagn. 2015 Sep;17(5):487-95
pubmed: 26320869
Clin Cancer Res. 2016 Oct 15;22(20):5097-5108
pubmed: 27026201
Cancer Discov. 2013 Feb;3(2):224-37
pubmed: 23220880
J Thorac Oncol. 2012 Jan;7(1):85-9
pubmed: 22071781
Int J Cancer. 2006 Dec 1;119(11):2586-91
pubmed: 16988931
J Clin Oncol. 2018 Jul 10;36(20):2105-2122
pubmed: 29846122
JAMA. 2004 Apr 28;291(16):1972-7
pubmed: 15113815
Am J Transl Res. 2015 Apr 15;7(4):733-50
pubmed: 26064441
Cancer Res. 2005 Mar 1;65(5):1642-6
pubmed: 15753357
J Biol Chem. 2003 Jun 27;278(26):23343-51
pubmed: 12686539
Mol Cell Biol. 1991 Feb;11(2):833-42
pubmed: 1671296
J Natl Cancer Inst. 2018 Dec 1;110(12):1409-1417
pubmed: 29718453
J Clin Oncol. 2018 Feb 20;36(6):536-542
pubmed: 29320312
Clin Breast Cancer. 2004 Apr;5(1):63-9
pubmed: 15140287
J Transl Med. 2015 Apr 11;13:116
pubmed: 25889497
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Ann Oncol. 2017 May 1;28(5):1070-1077
pubmed: 28453704
Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):E6205-14
pubmed: 26508629
Crit Rev Oncog. 2012;17(1):1-16
pubmed: 22471661
J Cell Biol. 2005 Nov 7;171(3):505-16
pubmed: 16275754
J Clin Oncol. 2018 Aug 20;36(24):2532-2537
pubmed: 29989854
Nature. 2018 Feb 8;554(7691):189-194
pubmed: 29420467
Clin Cancer Res. 2017 Jul 15;23(14):3529-3536
pubmed: 28053022
Clin Med Insights Oncol. 2016 Mar 28;10(Suppl 1):21-30
pubmed: 27042153
J Natl Cancer Inst. 2014 Jan;106(1):djt338
pubmed: 24317180
Breast Cancer Res. 2014 Mar 05;16(2):209
pubmed: 24887180
Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):474-9
pubmed: 19122144
Oncotarget. 2017 Nov 30;8(69):114371-114392
pubmed: 29371993

Auteurs

Funda Meric-Bernstam (F)

Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. fmeric@mdanderson.org.
Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Amber M Johnson (AM)

Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Ecaterina E Ileana Dumbrava (EEI)

Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Kanwal Raghav (K)

Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Kavitha Balaji (K)

Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Michelle Bhatt (M)

Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Rashmi K Murthy (RK)

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Jordi Rodon (J)

Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Sarina A Piha-Paul (SA)

Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH